精确肿瘤学
精密医学
药物反应
药品
药物开发
抗癌药
灵敏度(控制系统)
肿瘤科
医学
临床肿瘤学
抗癌药物
医学物理学
内科学
计算机科学
机器学习
癌症
药理学
病理
工程类
电子工程
作者
Katja Ovchinnikova,Jannis Born,Panagiotis Chouvardas,Marianna Rapsomaniki,Marianna Kruithof‐de Julio
标识
DOI:10.1038/s41698-024-00583-0
摘要
Machine learning (ML) models of drug sensitivity prediction are becoming increasingly popular in precision oncology. Here, we identify a fundamental limitation in standard measures of drug sensitivity that hinders the development of personalized prediction models - they focus on absolute effects but do not capture relative differences between cancer subtypes. Our work suggests that using z-scored drug response measures mitigates these limitations and leads to meaningful predictions, opening the door for sophisticated ML precision oncology models.
科研通智能强力驱动
Strongly Powered by AbleSci AI